相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
Cristiana Tanase et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
Yu-Fan Chuang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
Valeria Lucarini et al.
CANCERS (2021)
Myeloid Cells in Glioblastoma Microenvironment
Alessandra De Leo et al.
CELLS (2021)
Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
Natalia Ochocka et al.
NATURE COMMUNICATIONS (2021)
CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
Takayuki Morimoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
GD2 CAR T cells against human glioblastoma
Malvina Prapa et al.
NPJ PRECISION ONCOLOGY (2021)
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
Giuseppe Nicolo Fanelli et al.
GENES (2021)
Macrophages and microglia: the cerberus of glioblastoma
Alice Buonfiglioli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
Hao Wu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma
Guo-dong Zhu et al.
CELL DEATH & DISEASE (2021)
Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
Abdul Samad Basheer et al.
CANCERS (2021)
Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
Rikke Sick Andersen et al.
CANCERS (2021)
Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
Nadia Al-Sammarraie et al.
CELLS (2021)
Genome editing of Nf1, Pten, and Trp53 in neonatal mice induces glioblastomas positive for oligodendrocyte lineage transcription factor 2
Hiromi Yamamoto et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2021)
Targeting tumor-associated macrophages to synergize tumor immunotherapy
Xiaonan Xiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma
Muayad F. Almahariq et al.
IN VIVO (2021)
Role of myeloid cells in the immunosuppressive microenvironment in gliomas
Chiara Locarno et al.
IMMUNOBIOLOGY (2020)
Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages
Guan Sun et al.
AGING-US (2020)
The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma
Gueliz Acker et al.
EUROPEAN JOURNAL OF CANCER (2020)
Design and Characterization of an All-in-One Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
Katharina Zimmermann et al.
CANCERS (2020)
Immunotherapy for glioma: Current management and future application
Shengchao Xu et al.
CANCER LETTERS (2020)
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel et al.
CELL (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
Sabbir Khan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Magdalena Groblewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik et al.
CANCER DISCOVERY (2020)
Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells
Baole Zhang et al.
CLINICAL EPIGENETICS (2020)
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Helene Gregoire et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
Rih-Sheng Huang et al.
FRONTIERS IN IMMUNOLOGY (2020)
HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes
Tengfei Shi et al.
MOLECULAR BIOLOGY REPORTS (2020)
Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
Tsutomu Nakazawa et al.
CELLS (2020)
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
Tyler J. Alban et al.
FRONTIERS IN IMMUNOLOGY (2020)
A novel Cas9-targeted long-read assay for simultaneous detection of IDH1/2 mutations and clinically relevant MGMT methylation in fresh biopsies of diffuse glioma
Thidathip Wongsurawat et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross- presentation by dendritic cells in cancer
Alessio Ugolini et al.
JCI INSIGHT (2020)
cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity
Stephen T. Ferris et al.
NATURE (2020)
Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
Leila Akkari et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
GlioM&M: Web-based tool for studying circulating and infiltrating monocytes and macrophages in glioma
Erik R. Abels et al.
SCIENTIFIC REPORTS (2020)
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy
Shan Zhu et al.
PHARMACOLOGICAL RESEARCH (2020)
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Astrid De Boeck et al.
NATURE COMMUNICATIONS (2020)
Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma
Kenji Shono et al.
SCIENTIFIC REPORTS (2020)
Recent Advances in Immune Cell Therapy for Glioblastoma
Xianhui Kang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Fate mapping via CCR2-CreER mice reveals monocyte-to-microglia transition in development and neonatal stroke
Hong-Ru Chen et al.
SCIENCE ADVANCES (2020)
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
Clarissa Ribeiro Reily Rocha et al.
CELLS (2020)
Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
Xiangjun Tang et al.
FRONTIERS IN GENETICS (2020)
A simple and highly efficient method for multi-allelicCRISPR-Cas9editing in primary cell cultures
Pia Hoellerbauer et al.
CANCER REPORTS (2020)
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
Patricia P. Yee et al.
NATURE COMMUNICATIONS (2020)
The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function
Jun-Ho Lee et al.
JOURNAL OF CANCER (2020)
Genome Engineering Evolves Brain Tumor Modeling
Tomoyuki Koga et al.
NEUROLOGIA MEDICO-CHIRURGICA (2020)
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
S. John Liu et al.
GENOME BIOLOGY (2020)
Brain immunology and immunotherapy in brain tumours
John H. Sampson et al.
NATURE REVIEWS CANCER (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model
Surya Murty et al.
ONCOIMMUNOLOGY (2020)
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William Tomaszewski et al.
CLINICAL CANCER RESEARCH (2019)
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Takahiro Masuda et al.
NATURE (2019)
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
Jun Yan et al.
NATURE COMMUNICATIONS (2019)
Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma
Verena Haage et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
Karishma R. Rajani et al.
FRONTIERS IN ONCOLOGY (2019)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
Graham MacLeod et al.
CELL REPORTS (2019)
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma
Tatsuo Hori et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Yanxian Feng et al.
NATURE COMMUNICATIONS (2019)
Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
Ioanna Prionisti et al.
FRONTIERS IN PHARMACOLOGY (2019)
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
Rajkumar Noubade et al.
FRONTIERS IN IMMUNOLOGY (2019)
Ontogeny of Tumor-Associated Macrophages
Marie Laviron et al.
FRONTIERS IN IMMUNOLOGY (2019)
Wee1 Rather Than Plk1 Is Inhibited by AZD1775 at Therapeutically Relevant Concentrations
Angela Flavia Serpico et al.
CANCERS (2019)
Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
Reena P. Thomas et al.
CLINICAL CANCER RESEARCH (2019)
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye et al.
NATURE BIOTECHNOLOGY (2019)
LOX-1+PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
ErQing Chai et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema
Cameron J. Herting et al.
BRAIN (2019)
Mapping microglia states in the human brain through the integration of high-dimensional techniques
Roman Sankowski et al.
NATURE NEUROSCIENCE (2019)
Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology
David H. Gutmann et al.
NEURON (2019)
被撤回的出版物: CXCL8 Promotes Glioma Progression By Activating The JAK/STAT1/HIF-1 alpha/Snail Signaling Axis (Retracted article. See vol. 16, pg. 211, 2023)
Zhiming Chen et al.
ONCOTARGETS AND THERAPY (2019)
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion
Laura M. Prolo et al.
SCIENTIFIC REPORTS (2019)
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger et al.
FRONTIERS IN IMMUNOLOGY (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Brain Entangled: The Contribution of Neutrophil Extracellular Traps to the Diseases of the Central Nervous System
Aneta Manda-Handzlik et al.
CELLS (2019)
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
Tao Sun et al.
CANCER RESEARCH (2019)
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry
Chotima Boettcher et al.
NATURE NEUROSCIENCE (2019)
Glioblastoma: Microenvironment and Niche Concept
Davide Schiffer et al.
CANCERS (2019)
Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer
Maxim Shevtsov et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients
O. M. Koper et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2018)
Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
Soledad Urra et al.
ONCOTARGET (2018)
Vaccination in the immunotherapy of glioblastoma
Ziren Kong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
In-Young Jung et al.
CANCER RESEARCH (2018)
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
Eudocia Q. Lee et al.
CLINICAL CANCER RESEARCH (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Two distinct ontogenies confer heterogeneity to mouse brain microglia
Shrutokirti De et al.
DEVELOPMENT (2018)
Cancer-related circulating and tumor-associated neutrophils - subtypes, sources and function
Merav E. Shaul et al.
FEBS JOURNAL (2018)
When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma
Saskia Roesch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A Believer's Overview of Cancer Immunosurveillance and Immunotherapy
Olivera J. Finn
JOURNAL OF IMMUNOLOGY (2018)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Wouter B. L. van den Bossche et al.
NEURO-ONCOLOGY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
CD103+ Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model
Xiaolin Miao et al.
ONCOLOGY RESEARCH (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
Tomas Garzon-Muvdi et al.
Oncotarget (2018)
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma
Subhashree Nayak et al.
SCIENTIFIC REPORTS (2018)
Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer
Lisa Sevenich
FRONTIERS IN IMMUNOLOGY (2018)
Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function
Kathryn M. Lenz et al.
FRONTIERS IN IMMUNOLOGY (2018)
Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals
Toshihiko Komai et al.
FRONTIERS IN IMMUNOLOGY (2018)
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma
Joseph DiDomenico et al.
ONCOIMMUNOLOGY (2018)
Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
Toshiharu Murakami et al.
ANTICANCER RESEARCH (2018)
Genetically engineered cerebral organoids model brain tumor formation (vol 15, pg 631, 2018)
Shan Bian et al.
NATURE METHODS (2018)
Immunotherapy in Glioblastoma
Jessica A. Wilcox et al.
WORLD NEUROSURGERY (2018)
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma
Kartik Angara et al.
NEOPLASIA (2018)
Harnessing the immune system in glioblastoma
Nicholas F. Brown et al.
BRITISH JOURNAL OF CANCER (2018)
Lin-CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade
Catherine T. Flores et al.
NATURE COMMUNICATIONS (2018)
CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma
Francesca Lepore et al.
FRONTIERS IN IMMUNOLOGY (2018)
CART Immunotherapy: Development Success, and Translation to Malignant Gliomas and Other Solid Tumors
Anna C. Filley et al.
FRONTIERS IN ONCOLOGY (2018)
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban et al.
JCI INSIGHT (2018)
The emerging role of oncolytic virus therapy against cancer
Luke Russell et al.
CHINESE CLINICAL ONCOLOGY (2018)
Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
Antoine Schernberg et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2018)
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
Tatjana Wallmann et al.
ISCIENCE (2018)
Advances and challenges: dendritic cell vaccination strategies for glioblastoma
Teilo H. Schaller et al.
EXPERT REVIEW OF VACCINES (2017)
Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells
Jialiang Wang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival
Matthew Mason et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
Rachid El Fatimy et al.
MOLECULAR THERAPY (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan D. Chow et al.
NATURE NEUROSCIENCE (2017)
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
Filippo Veglia et al.
NATURE COMMUNICATIONS (2017)
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2017)
Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
Huaiyang Zhu et al.
ONCOTARGET (2017)
Cellular and Molecular Characterization of Microglia: A Unique Immune Cell Population
Carole Sousa et al.
FRONTIERS IN IMMUNOLOGY (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade
Changbin Zhu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas
Anna Gieryng et al.
SCIENTIFIC REPORTS (2017)
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai et al.
CLINICAL CANCER RESEARCH (2017)
Cancer-promoting mechanisms of tumor-associated neutrophils
Brian Hurt et al.
AMERICAN JOURNAL OF SURGERY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
Eric S. Yvon et al.
CYTOTHERAPY (2017)
Dendritic cells in cancer: the role revisited
Filippo Veglia et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors
Susan Brandenburg et al.
ACTA NEUROPATHOLOGICA (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski et al.
NEURO-ONCOLOGY (2016)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients
Afsar Rahbar et al.
ONCOIMMUNOLOGY (2016)
The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Kiavash Movahedi et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients
Mev Dominguez-Valentin et al.
CANCER RESEARCH (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Sall1 is a transcriptional regulator defining microglia identity and function
Anne Buttgereit et al.
NATURE IMMUNOLOGY (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function
Paul R. Gielen et al.
NEURO-ONCOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
New tools for studying microglia in the mouse and human CNS
Mariko L. Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Myeloid-derived suppressor cells in gliomas
Anna Gieryng et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
Oncolytic viruses as immunotherapy: progress and remaining challenges
Laure Aurelian
ONCOTARGETS AND THERAPY (2016)
Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients
Song Han et al.
ONCOLOGY LETTERS (2016)
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
Damya Laoui et al.
NATURE COMMUNICATIONS (2016)
TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype
Fan Zhang et al.
ONCOTARGET (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Elena Codrici et al.
STEM CELLS INTERNATIONAL (2016)
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Evelina Martinenaite et al.
OncoImmunology (2016)
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
Stefano Soldano et al.
PLOS ONE (2016)
Immune Evasion Strategies of Glioblastoma
Seyed-Mostafa Razavi et al.
FRONTIERS IN SURGERY (2016)
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine et al.
SCIENCE IMMUNOLOGY (2016)
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Se Jeong Lee et al.
BMC CANCER (2015)
Circulating biomarker panels for targeted therapy in brain tumors
Cristiana Tanase et al.
FUTURE ONCOLOGY (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
C-Myb+ Erythro-Myeloid Progenitor-Derived Fetal Monocytes Give Rise to Adult Tissue-Resident Macrophages
Guillaume Hoeffel et al.
IMMUNITY (2015)
Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes
Baisakhi Raychaudhuri et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
Paul R. Gielen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Immunosuppressive mechanisms in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2015)
Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - A pilot study
Przemyslaw Zadora et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2015)
Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1
Frank Szulzewsky et al.
PLOS ONE (2015)
Engineering CAR-T cells: Design concepts
Shivani Srivastava et al.
TRENDS IN IMMUNOLOGY (2015)
Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma
Liu Yang et al.
ONCOTARGETS AND THERAPY (2015)
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Marc Zuckermann et al.
NATURE COMMUNICATIONS (2015)
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
Xi Feng et al.
ONCOTARGET (2015)
Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
Emeline Tabouret et al.
ONCOTARGET (2015)
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Jitka Y. Sagiv et al.
CELL REPORTS (2015)
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
Chad M. Toledo et al.
CELL REPORTS (2015)
Microglia versus myeloid cell nomenclature during brain inflammation
Melanie Greter et al.
FRONTIERS IN IMMUNOLOGY (2015)
RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth
Anne C. Solga et al.
NEOPLASIA (2015)
Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
Powell Perng et al.
FRONTIERS IN ONCOLOGY (2015)
RNA-Sequencing Reveals Oligodendrocyte and Neuronal Transcripts in Microglia Relevant to Central Nervous System Disease
Anne C. Solga et al.
GLIA (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
CNS macrophages and peripheral myeloid cells in brain tumours
Rainer Glass et al.
ACTA NEUROPATHOLOGICA (2014)
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
M. J. Walters et al.
BRITISH JOURNAL OF CANCER (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Neutrophils Promote the Malignant Glioma Phenotype through S100A4
Ji Liang et al.
CLINICAL CANCER RESEARCH (2014)
The role of regulatory T-cells in glioma immunology
Yinn Cher Ooi et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways
Patrick L. Raber et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages
Anna Carolina Carvalho da Fonseca et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Roberto Wuerth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Fractalkine regulation of microglial physiology and consequences on the brain and behavior
Rosa Chiara Paolicelli et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
Anup Kumar Singh et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
R. M. Bambury et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Macrophage plasticity and polarization in tissue repair and remodelling
Alberto Mantovani et al.
JOURNAL OF PATHOLOGY (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson et al.
NEURO-ONCOLOGY (2013)
Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
Simon Tazzyman et al.
SEMINARS IN CANCER BIOLOGY (2013)
Origin and differentiation of microglia
Florent Ginhoux et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Macrophages and chemokines as mediators of angiogenesis
Jennifer L. Owen et al.
FRONTIERS IN PHYSIOLOGY (2013)
Natural and induced T regulatory cells in cancer
Dennis O. Adeegbe et al.
FRONTIERS IN IMMUNOLOGY (2013)
The tumor microenvironment: a pitch for multiple players
Giovanna Schiavoni et al.
FRONTIERS IN ONCOLOGY (2013)
Brain dendritic cells: biology and pathology
Paul M. D'Agostino et al.
ACTA NEUROPATHOLOGICA (2012)
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2012)
Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
Muzlifah Haniffa et al.
IMMUNITY (2012)
Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway
Xian-zong Ye et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model
Shu-Chi Wang et al.
LABORATORY INVESTIGATION (2012)
Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling
Salvatore J. Coniglio et al.
MOLECULAR MEDICINE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target
Mizuhiko Terasaki et al.
BRAIN TUMOR PATHOLOGY (2011)
Chemokine receptor CXCR3 promotes growth of glioma
Che Liu et al.
CARCINOGENESIS (2011)
Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I
Trisha R. Sippel et al.
CLINICAL CANCER RESEARCH (2011)
Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Jennifer Lohr et al.
CLINICAL CANCER RESEARCH (2011)
The chemokine network, a newly discovered target in high grade gliomas
U. M. Domanska et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Temozolomide-induced modification of the CXC chemokine network in experimental gliomas
Kiss
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
Yi-fang Ping et al.
JOURNAL OF PATHOLOGY (2011)
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri et al.
NEURO-ONCOLOGY (2011)
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors
Derek A. Wainwright et al.
NEURO-ONCOLOGY (2011)
Microglial cell origin and phenotypes in health and disease
Kaoru Saijo et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1
Nicole M. Warrington et al.
CANCER RESEARCH (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
The chemokine system in cancer biology and therapy
Alberto Mantovani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1
Marco Erreni et al.
EUROPEAN JOURNAL OF CANCER (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
α4β1 Integrin Mediates the Recruitment of Immature Dendritic Cells across the Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis
Pooja Jain et al.
JOURNAL OF IMMUNOLOGY (2010)
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Joannes F. M. Jacobs et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Chemokines and glioma: Invasion and more
Giuseppe Sciume et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1
Giuseppe Sciume et al.
NEURO-ONCOLOGY (2010)
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens
Kimberly R. Jordan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Phagocyte partnership during the onset and resolution of inflammation
Oliver Soehnlein et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature
G-One Ahn et al.
ANGIOGENESIS (2009)
The development and function of regulatory T cells
Creg J. Workman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry
Vassilis Samaras et al.
HUMAN IMMUNOLOGY (2009)
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1
Makoto Okada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Induced interleukin-8 expression in gliomas by tumor-associated macrophages
Tse-Ming Hong et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
Amy B. Heimberger et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Polymorphism in the Microglial Cell-Mobilizing CX3CR1 Gene Is Associated With Survival in Patients With Glioblastoma
Mathieu Rodero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma
Chiara Gabellini et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16
Andreas Ludwig et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation
Seema V. Maru et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes
Che Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6
Kirsten Hattermann et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1
Nicole M. Warrington et al.
CANCER RESEARCH (2007)
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Zhongxing Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas
Abdeljabar El Andaloussi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth
Girish C. Daginakatte et al.
HUMAN MOLECULAR GENETICS (2007)
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Serena Pellegatta et al.
CANCER RESEARCH (2006)
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors
Abdeljabar El Andaloussi et al.
JOURNAL OF NEUROSURGERY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells
A Ludwig et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Defining the antigen-specific T-Cell response to vaccination and poly(I:C)/TLR3 signaling -: Evidence of enhanced primary and memory CD8 T-Cell responses and antitumor immunity
ML Salem et al.
JOURNAL OF IMMUNOTHERAPY (2005)
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent
S Jodele et al.
CANCER RESEARCH (2005)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
DJ Brat et al.
NEURO-ONCOLOGY (2005)
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma
Y Akasaki et al.
JOURNAL OF IMMUNOLOGY (2004)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis
AH Li et al.
JOURNAL OF IMMUNOLOGY (2003)
Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils
WS Hor et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Tumour escape from immune surveillance through dendritic cell inactivation
AP Vicari et al.
SEMINARS IN CANCER BIOLOGY (2002)
Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice
CC Chio et al.
BRITISH JOURNAL OF CANCER (2001)
CXC chemokine receptor 4 expression and function in human astroglioma cells
JW Oh et al.
JOURNAL OF IMMUNOLOGY (2001)
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta
W Wick et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
CL Addison et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
